My watch list
my.bionity.com  
Login  

Alterations in the p53 Pathway and p16INK4a Expression Predict Overall Survival in Metastatic Melanoma Patients Treated with Dacarbazine

Alterations in the p53 Pathway and p16INK4a Expression Predict Overall Survival in Metastatic Melanoma Patients Treated with Dacarbazine

Journal of Investigative Dermatology 130, 2514 (October 2010). doi:10.1038/jid.2010.138

Authors: Christian Busch, Jürgen Geisler, Stian Knappskog, Johan R Lillehaug & Per E Lønning

Authors:   Christian Busch, J|[uuml]|rgen Geisler, Stian Knappskog, Johan R Lillehaug, Per E L|[oslash]|nning
Journal:   Journal of Investigative Dermatology
Volume:   130
edition:   10
Year:   2010
Pages:   2514
DOI:   10.1038/jid.2010.138
Publication date:   27-May-2010
Facts, background information, dossiers
More about Nature Publishing Group
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE